Table 1 Main characteristics of the eligible studies.
Study [Year] | Time interval of collected data | Total | Men/ women | UICC stage | Localization | HPV subtypes | Mean age [Year] | |
|---|---|---|---|---|---|---|---|---|
1 | Wittekindt C23 | — | 34 | 25/9 | I-IV | OPSCC | 16, 33 | 61 |
2 | Smith EM24 | 1994–2004 | 301 | 188/113 | I-IV | all | 16, 33, 18 | |
3 | Kong CS25 | — | 99 | 69/13 | II-IV | all | 16, 18, 33 | |
4 | Weinberger PM26 | 1980–1999 (Yale), 2004–2007 (Georgia) | 140 | 106/34 | I-IV | all | 16, 18 | 60.3 |
5 | Heath S27 | 2004–2007 | 83 | 48/35 | I-IV | all | HPV16 | 64 |
6 | Park WS28 | 2002–2007 | 93 | 80/13 | I-IV | OPSCC | 16, 18, 33 | 62.1 |
7 | Holzinger D29 | 1990–2008 | 199 | 146/50 | I-IV | OPSCC | 16, 18, 33, 35 | 57 |
8 | Liang C30 | 1999–2003 | 844 | I-IV | all | 16 | ||
9 | Park K31 | 2000–2008 | 142 | 73/6 | III-IV | OPSCC | 54 | |
10 | Evans M32 | 2001–2006 | 147 | 104/34 | I-IV | all | 16, 18, 33, 56 | 58.1 |
11 | Stephen JK34 | 1986–2003 | 80 | 66/14 | I-IV | all | 16 | |
12 | Rietbergen MM35 | 2000–2006 | 841 | I-IV | OPSCC | 16, 35, 33, 18, 45, 58 | ||
13 | Huang H, 201336 | 1999–2009 | 66 | I-IV | OPSCC | 16,33,11,35,52,54,58 | 59 | |
14 | Semrau R41 | 2000–2008 | 52 | 42/10 | III-IV | OPSCC | 16, 18, 33, 35 | 56.3 |
15 | Melkane AE33 | 2007–2009 | 133 | 94/39 | I-IV | OPSCC | 16, 18, 33 | 59 |
16 | Salazar CR37 | — | 158 | 110/43 | I-IV | OPSCC | 16 | |
17 | Heiduschka G39 | 2002–2013 | 103 | 46/17 | II-IV | OPSCC | 60.5 | |
18 | Chung CH40 | — | 683 | III-IV | all non-OPSCC | 58 | ||
19 | Ramshankar V42 | 1995–2007 | 167 | 108/48 | I-II | HNSCC | 16 | |
20 | Xu Y38 | 2004–2013 | 278 | 229/27 | I-IV | all | 11, 16, 33 | |
21 | Liu JC43 | 1990–2010 | 44 | 30/14 | I-IV | OPSCC | 16, 35 | 64 |
22 | Saito Y44 | 2004–2012 | 167 | 130/20 | I-IV | all | 64 | |
23 | Descamps G45 | 218 | 173/45 | II-IV | HNSCC | |||
24 | Mazul AL46 | 2002–2006 | 238 | I-IV | OPSCC | 6,11,16,18, 26,31,33,35,39,58,59,82 | ||
25 | Gronhoj Larsen C47 | 2000–2014 | 1542 | I-IV | OPSCC |